New research shows that the Janus kinase (JAK) inhibitor abrocitinib, approved in Canada for the treatment of moderate-to-severe atopic...

Researchers have discovered a new mediator of itch in prurigo nodularis (PN), which they say could lead to new therapeutic options for...